Max Healthcare Institute Ltd is one of India’s leading healthcare providers, offering comprehensive medical services across a network of hospitals and facilities. Renowned for its advanced medical technology, skilled professionals, and patient-centric approach, the company delivers high-quality care in specialties such as cardiology, oncology, neurology, and orthopedics. Max Healthcare Share Price on NSE as of 18 January 2025 is 1,026.00 INR. Here are more details on Max Healthcare Share Price Target 2025, 2026 to 2030.
Max Healthcare Institute Ltd: Market Overview
- Open: ₹1,051.25
- High: ₹1,056.45
- Low: ₹1,008.70
- Previous Close: ₹1,049.95
- Volume: 2,750,545
- Value (Lacs): ₹28,238.47
- VWAP: ₹1,026.68
- UC Limit: ₹1,154.90
- LC Limit: ₹944.95
- 52 Week High: ₹1,227.95
- 52 Week Low: ₹694.80
- Mkt Cap (Rs. Cr.): ₹99,803
- Face Value: ₹10
Max Healthcare Share Price Chart
Max Healthcare Share Price Target Tomorrow 2025 To 2030
Max Healthcare Share Price Target Years | Share Price Target |
2025 | ₹1240 |
2026 | ₹1560 |
2027 | ₹1876 |
2028 | ₹2190 |
2029 | ₹2535 |
2030 | ₹2865 |
Max Healthcare Share Price Target 2025
Max Healthcare share price target 2025 Expected target could be ₹1240. Here are 4 Key Factors Affecting Growth for “Max Healthcare Share Price Target 2025”
- Expansion of Healthcare Infrastructure: Max Healthcare’s plans to expand its network of hospitals and healthcare facilities, particularly in underserved regions, could boost revenue growth and attract more patients.
- Rising Demand for Quality Healthcare: Increased health awareness, a growing middle-class population, and higher spending on medical treatments in India are likely to drive demand for the company’s services.
- Focus on Specialized Treatments: The company’s emphasis on high-margin specialized services like oncology, cardiology, and organ transplants can significantly enhance profitability and attract patients seeking advanced care.
-
Medical Tourism Growth: India’s reputation as a cost-effective destination for high-quality medical procedures can benefit Max Healthcare, as it continues to cater to international patients and expand its global presence.
Max Healthcare Share Price Target 2030
Max Healthcare share price target 2030 Expected target could be ₹2865. Here are 4 Risks and Challenges for “Max Healthcare Share Price Target 2030”
- Regulatory and Policy Risks: Changes in government healthcare policies, pricing regulations, or compliance requirements could impact the company’s profitability and operational flexibility.
- Intense Competition: The healthcare sector is highly competitive, with both established players and new entrants vying for market share, which could pressure Max Healthcare’s growth and margins.
- Rising Operational Costs: Increasing costs related to advanced medical technology, skilled healthcare personnel, and facility maintenance could affect profit margins if not managed efficiently.
-
Economic and Global Health Crises: Potential economic downturns or global health emergencies (e.g., pandemics) could disrupt patient inflow, supply chains, and international medical tourism, posing significant challenges to revenue stability.
Shareholding Pattern For Max Healthcare Institute Ltd
- Promoters: 23.74%
- FII: 57.29%
- DII: 15.14%
- Public: 3.83%
Max Healthcare Institute Ltd Financials
(INR) | 2024 | Y/Y change |
Revenue | 54.06B | 18.49% |
Operating expense | 20.78B | 14.97% |
Net income | 10.58B | -4.16% |
Net profit margin | 19.56 | -19.14% |
Earnings per share | 10.84 | -4.58% |
EBITDA | 14.82B | 21.21% |
Effective tax rate | 22.54% | — |
Read Also:- MAZDOCK Share Price Target Tomorrow From 2025 To 2030- Prediction, Market Overview